Improvement of sarcoidosis under therapy with interferon-α 2b for chronic hepatitis B virus infection

被引:15
|
作者
Luers, C [1 ]
Sudhop, T
Spengler, U
Berthold, HK
机构
[1] Univ Bonn, Dept Clin Pharmacol, D-5300 Bonn, Germany
[2] Univ Bonn, Dept Gen Internal Med, D-5300 Bonn, Germany
关键词
D O I
10.1016/S0168-8278(99)80085-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:347 / 347
页数:1
相关论文
共 50 条
  • [1] Efficacy of hepatitis B vaccination and interferon-α-2b combination therapy versus interferon-α-2b monotherapy in children with chronic hepatitis B
    Helvaci, M
    Kizilgunesler, A
    Kasirga, E
    Ozbal, E
    Kuzu, M
    Sozen, G
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (07) : 785 - 791
  • [2] Benefit of interferon-α2b in a patient with unresectable hepatoma and chronic infection with hepatitis C virus
    Locker, GJ
    Mader, RM
    Steiner, B
    Wenzl, E
    Zielinski, CC
    Steger, GG
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (02) : 251 - 253
  • [3] The development of hepatic granulomas following interferon-α2b therapy for chronic hepatitis C infection
    Ryan, BM
    McDonald, GSA
    Pilkington, R
    Kelleher, D
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (04) : 349 - 351
  • [4] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [5] Interferon-α2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection -: A prospective controlled trial
    Martin, P
    Hann, HW
    Westerberg, S
    Muñoz, SJ
    Rubin, R
    Maddrey, WC
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (04) : 875 - 879
  • [6] Interferon-α 2b Therapy Is Efficacious in Asian-Americans with Chronic Hepatitis B Infection: A Prospective Controlled Trial
    Paul Martin
    Hie-Won Hann
    Sharon Westerberg
    Santiago J. Munoz
    Raphael Rubin
    Willis C. Maddrey
    [J]. Digestive Diseases and Sciences, 1998, 43 : 875 - 879
  • [7] Treatment of chronic hepatitis delta with pegylated interferon-α2b
    Erhardt, Andreas
    Gerlich, Wolfram
    Starke, Christine
    Wend, Ulrike
    Donner, Andreas
    Sagir, Abdurrahman
    Heintges, Tobias
    Haeussinger, Dieter
    [J]. LIVER INTERNATIONAL, 2006, 26 (07) : 805 - 810
  • [8] Interferon-α-2b and ribavirin for retreatment of chronic hepatitis C
    Dettmer, RM
    Reinus, JF
    Clain, DJ
    Aytaman, A
    Levendoglu, H
    Bloom, AA
    Isaacson, MP
    Spinnell, M
    Meyer, D
    Sarabanchong, V
    Zhang, YT
    Garcia-Carrasquillo, RJ
    Markowitz, DD
    Magun, AM
    Worman, HJ
    [J]. HEPATO-GASTROENTEROLOGY, 2002, 49 (45) : 758 - 763
  • [9] Interferon-α2b induced facial erythema in a woman with chronic hepatitis C infection
    Tursen, U
    Kaya, TI
    Ikizoglu, G
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2002, 16 (03) : 285 - 286
  • [10] Serum zinc as a factor predicting response to interferon-α2b therapy in children with chronic hepatitis B
    Özbal, E
    Helvaci, M
    Kasirga, E
    Akdenizoglu, F
    Kizilgünesler, A
    [J]. BIOLOGICAL TRACE ELEMENT RESEARCH, 2002, 90 (1-3) : 31 - 38